Broomfield, CO (December 16, 2013) —ForeignExchange Translations, Inc., the leader in translations for the medical device and pharmaceutical industries, today announced the hire of Dana Weiss, as Director of Linguistic Validation.
Dana Weiss will lead the expansion of ForeignExchange’s linguistic validation offering and brings 10 years of extensive expertise within Patient Reported Outcomes (PROs). Dana’s experience includes working with authors of internationally recognized instruments, as well as global teams of linguists and clinicians to validate them into over 50 languages.
Andres Heuberger, president of ForeignExchange said, “We are very excited about onboarding Dana Weiss, her vast experience in Patient Reported Outcomes and experience working at CORE (Center on Outcomes, Research and Education) will further strengthen ForeignExchange’s linguistic validation solution offering.
About ForeignExchange Translations
ForeignExchange Translations, Inc. is the leader in medical translation. ForeignExchange's solutions are based on its proprietary Multilingual Compliance Process, combining expert linguists, best-of-breed technology, and measurable translation quality in a robust and scalable process that can be deployed in multiple languages simultaneously. ForeignExchange provides linguistic validation, globalization consulting, software localization, and medical translation solutions to clients such as Abbott (NYSE:ABT), Novartis (NYSE:NVS), Johnson & Johnson (NYSE:JNJ), and Covidien (NYSE:COV).
For questions and inquiries, please visit www.fxtrans.com
or contact Bryan Favero at bryan.favero@fxtrans.com
Help employers find you! Check out all the jobs and post your resume.
